EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Dysbiosis and Plasma Trimethylamine Oxide Are Associated with Subclinical Coronary Atherosclerosis in Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

Kittiya Islam iD, Pattida Kongsomboonchoke iD, Maneerat Chayanupatkul iD, Monravee Tumkosit iD, Pairoj Chattranukulchai, Pinidphon Prombutara, Pisit Tangkijvanich iD

Nutrients · 2025

DOI: 10.3390/nu17172759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Kittiya Islam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Chulalongkorn University, Bangkok 10330, Thailand. Hauptthemen laut MEDLINE: Methylamines, Dysbiosis, Gastrointestinal Microbiome, Obesity. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B), National Research Council of Thailand, Second Century Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Gut microbiota has been implicated in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) and cardiovascular disease (CVD). This study aimed to identify associations between gut dysbiosis and MASLD, regarding body mass index (BMI) and subclinical coronary atherosclerosis (SCA).

Methods

We conducted a cross-sectional study of 202 patients with MASLD who had no previous history of CVD. The severity of MASLD was evaluated using a magnetic resonance imaging-based method, and SCA was measured by assessing coronary artery calcification (CAC). Gut microbiota was assessed in fecal specimens using sequencing targeting the V4 region of the 16S rRNA gene.

Results

Our results demonstrated that gut microbial profiles between low- and high-BMI groups (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylaminesDysbiosisGastrointestinal MicrobiomeObesityCoronary Artery DiseaseFatty LiverHumansMaleFemaleMiddle AgedCross-Sectional StudiesAgedBody Mass IndexFeces

Stichwörter der Autor:innen

atherosclerosiscardiovascular diseasegut microbiotaobesityshort-chain fatty acidssteatotic liver diseasetrimethylamine oxide

Substanzen

Methylaminestrimethyloxamine

Autor:innen und Institutionen

  • Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Chulalongkorn University, Bangkok 10330, Thailand.
  • Center of Excellence in Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Radiology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
  • Division of Cardiovascular Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University, and Cardiac Center, King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
  • Mod Gut Co., Ltd., Bangkok 10600, Thailand.
  • Omics Sciences and Bioinformatics Center, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.

ORCID-Profile: Kittiya Islam, Pattida Kongsomboonchoke, Maneerat Chayanupatkul, Monravee Tumkosit, Pisit Tangkijvanich

Förderung

  • Program Management Unit for Human Resources & Institutional Development, Research and Innovation (PMU-B)
  • National Research Council of Thailand
  • Second Century Fund
  • NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation
  • Second Century Fund (C2F), Chulalongkorn University

Zitieren

APA

Islam, K., Kongsomboonchoke, P., Chayanupatkul, M., Tumkosit, M., Chattranukulchai, P., Prombutara, P., & Tangkijvanich, P. (2025). Gut Dysbiosis and Plasma Trimethylamine Oxide Are Associated with Subclinical Coronary Atherosclerosis in Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients. https://doi.org/10.3390/nu17172759

Vancouver

Islam K, Kongsomboonchoke P, Chayanupatkul M, Tumkosit M, Chattranukulchai P, Prombutara P, et al. Gut Dysbiosis and Plasma Trimethylamine Oxide Are Associated with Subclinical Coronary Atherosclerosis in Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients. 2025. doi:10.3390/nu17172759

BibTeX
@article{Islam2025,
  author = {Islam, Kittiya and Kongsomboonchoke, Pattida and Chayanupatkul, Maneerat and Tumkosit, Monravee and Chattranukulchai, Pairoj and Prombutara, Pinidphon and Tangkijvanich, Pisit},
  title = {Gut Dysbiosis and Plasma Trimethylamine Oxide Are Associated with Subclinical Coronary Atherosclerosis in Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17172759}
}
Kostenlos starten →